S&P 500   4,279.05 (-0.21%)
DOW   33,357.21 (-0.45%)
QQQ   360.59 (+0.65%)
AAPL   173.52 (+1.35%)
MSFT   318.30 (+0.81%)
META   305.71 (+1.83%)
GOOGL   133.65 (+2.13%)
AMZN   129.29 (+1.71%)
TSLA   250.03 (-0.08%)
NVDA   448.11 (+3.02%)
NIO   8.77 (-2.99%)
BABA   86.32 (-0.48%)
AMD   102.23 (-0.57%)
T   14.85 (-1.13%)
F   12.32 (-0.81%)
MU   67.77 (-0.38%)
CGC   0.79 (+0.51%)
GE   109.41 (-1.03%)
DIS   81.07 (+0.02%)
AMC   7.89 (-1.25%)
PFE   33.22 (+0.15%)
PYPL   58.79 (+0.56%)
NFLX   381.58 (+1.05%)
S&P 500   4,279.05 (-0.21%)
DOW   33,357.21 (-0.45%)
QQQ   360.59 (+0.65%)
AAPL   173.52 (+1.35%)
MSFT   318.30 (+0.81%)
META   305.71 (+1.83%)
GOOGL   133.65 (+2.13%)
AMZN   129.29 (+1.71%)
TSLA   250.03 (-0.08%)
NVDA   448.11 (+3.02%)
NIO   8.77 (-2.99%)
BABA   86.32 (-0.48%)
AMD   102.23 (-0.57%)
T   14.85 (-1.13%)
F   12.32 (-0.81%)
MU   67.77 (-0.38%)
CGC   0.79 (+0.51%)
GE   109.41 (-1.03%)
DIS   81.07 (+0.02%)
AMC   7.89 (-1.25%)
PFE   33.22 (+0.15%)
PYPL   58.79 (+0.56%)
NFLX   381.58 (+1.05%)
S&P 500   4,279.05 (-0.21%)
DOW   33,357.21 (-0.45%)
QQQ   360.59 (+0.65%)
AAPL   173.52 (+1.35%)
MSFT   318.30 (+0.81%)
META   305.71 (+1.83%)
GOOGL   133.65 (+2.13%)
AMZN   129.29 (+1.71%)
TSLA   250.03 (-0.08%)
NVDA   448.11 (+3.02%)
NIO   8.77 (-2.99%)
BABA   86.32 (-0.48%)
AMD   102.23 (-0.57%)
T   14.85 (-1.13%)
F   12.32 (-0.81%)
MU   67.77 (-0.38%)
CGC   0.79 (+0.51%)
GE   109.41 (-1.03%)
DIS   81.07 (+0.02%)
AMC   7.89 (-1.25%)
PFE   33.22 (+0.15%)
PYPL   58.79 (+0.56%)
NFLX   381.58 (+1.05%)
S&P 500   4,279.05 (-0.21%)
DOW   33,357.21 (-0.45%)
QQQ   360.59 (+0.65%)
AAPL   173.52 (+1.35%)
MSFT   318.30 (+0.81%)
META   305.71 (+1.83%)
GOOGL   133.65 (+2.13%)
AMZN   129.29 (+1.71%)
TSLA   250.03 (-0.08%)
NVDA   448.11 (+3.02%)
NIO   8.77 (-2.99%)
BABA   86.32 (-0.48%)
AMD   102.23 (-0.57%)
T   14.85 (-1.13%)
F   12.32 (-0.81%)
MU   67.77 (-0.38%)
CGC   0.79 (+0.51%)
GE   109.41 (-1.03%)
DIS   81.07 (+0.02%)
AMC   7.89 (-1.25%)
PFE   33.22 (+0.15%)
PYPL   58.79 (+0.56%)
NFLX   381.58 (+1.05%)
NASDAQ:PIII

P3 Health Partners (PIII) Stock Forecast, Price & News

$1.67
+0.20 (+13.61%)
(As of 10:51 AM ET)
Compare
Today's Range
$1.45
$1.71
50-Day Range
$1.31
$2.79
52-Week Range
$0.70
$6.02
Volume
153,715 shs
Average Volume
461,699 shs
Market Capitalization
$522.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00

P3 Health Partners MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
199.4% Upside
$5.00 Price Target
Short Interest
Bearish
8.54% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.30mentions of P3 Health Partners in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$1.43 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.96) to ($0.73) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.94 out of 5 stars

Medical Sector

686th out of 969 stocks

Medical Care Facilities Industry

1st out of 1 stocks


PIII stock logo

About P3 Health Partners (NASDAQ:PIII) Stock

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.

PIII Price History

PIII Stock News Headlines

BTIG Keeps Their Buy Rating on P3 Health Partners (PIII)
How is This "Hidden Gem" Thriving in a Turbulent Market?
While Wall Street flounders and giants like Amazon & Microsoft lay off thousands... One overlooked company has been quietly achieving over 400% growth. How? By buying, building, and scaling a portfolio of promising brands in high-margin, recession-resistant verticals.
How is This "Hidden Gem" Thriving in a Turbulent Market?
While Wall Street flounders and giants like Amazon & Microsoft lay off thousands... One overlooked company has been quietly achieving over 400% growth. How? By buying, building, and scaling a portfolio of promising brands in high-margin, recession-resistant verticals.
P3 Health Partners On Solid Path To Profitability
See More Headlines
Receive PIII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter.

PIII Company Calendar

Last Earnings
8/07/2023
Today
10/02/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PIII
Fax
N/A
Employees
600
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.00
High Stock Price Forecast
$5.00
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
+240.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-270,130,000.00
Pretax Margin
-59.36%

Debt

Sales & Book Value

Annual Sales
$1.05 billion
Cash Flow
$36.75 per share
Book Value
$0.15 per share

Miscellaneous

Free Float
259,334,000
Market Cap
$459.64 million
Optionable
Not Optionable
Beta
1.39
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Sherif Abdou F.A.C.E.P. (Age 62)
    FACP, M.D., Co-Founder, CEO & Director
    Comp: $7.1M
  • Dr. Amir Bacchus M.B.A. (Age 58)
    M.D., Co-Founder, Chief Medical Officer & Director
    Comp: $4.3M
  • Mr. Atul Kavthekar
    CFO & Chief Accounting Officer
  • Mr. William Bettermann
    Exec. VP & COO
  • Mr. Devery Goodey
    Sr. VP of Technology
  • Ms. Karen Blomquist
    VP of Investor Relations
  • Ms. Jessica Puathasnanon
    Chief Legal Officer, Gen. Counsel & Sec.
  • Ms. Kassi Belz APR
    Exec. VP of Communications, Culture & Engagement
  • Ms. Lorie Glisson CPA
    Florida Market Pres
  • Mr. Todd Lefkowitz MHA
    Chief Managed Care Officer













PIII Stock - Frequently Asked Questions

Should I buy or sell P3 Health Partners stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for P3 Health Partners in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" PIII shares.
View PIII analyst ratings
or view top-rated stocks.

What is P3 Health Partners' stock price forecast for 2023?

2 Wall Street analysts have issued twelve-month price targets for P3 Health Partners' stock. Their PIII share price forecasts range from $5.00 to $5.00. On average, they expect the company's share price to reach $5.00 in the next twelve months. This suggests a possible upside of 240.1% from the stock's current price.
View analysts price targets for PIII
or view top-rated stocks among Wall Street analysts.

How have PIII shares performed in 2023?

P3 Health Partners' stock was trading at $1.84 at the beginning of the year. Since then, PIII shares have decreased by 20.1% and is now trading at $1.47.
View the best growth stocks for 2023 here
.

Are investors shorting P3 Health Partners?

P3 Health Partners saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 4,140,000 shares, an increase of 36.2% from the August 31st total of 3,040,000 shares. Based on an average trading volume of 472,000 shares, the short-interest ratio is presently 8.8 days. Approximately 8.5% of the company's shares are sold short.
View P3 Health Partners' Short Interest
.

When is P3 Health Partners' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our PIII earnings forecast
.

How were P3 Health Partners' earnings last quarter?

P3 Health Partners Inc. (NASDAQ:PIII) issued its quarterly earnings data on Monday, August, 7th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.24) by $0.15. The company earned $329.09 million during the quarter, compared to the consensus estimate of $303.30 million. P3 Health Partners had a negative trailing twelve-month return on equity of 2,471.27% and a negative net margin of 10.92%.

What guidance has P3 Health Partners issued on next quarter's earnings?

P3 Health Partners updated its FY 2023 earnings guidance on Monday, August, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.20 billion-$1.25 billion, compared to the consensus revenue estimate of $1.24 billion.

What is P3 Health Partners' stock symbol?

P3 Health Partners trades on the NASDAQ under the ticker symbol "PIII."

How do I buy shares of P3 Health Partners?

Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is P3 Health Partners' stock price today?

One share of PIII stock can currently be purchased for approximately $1.47.

How much money does P3 Health Partners make?

P3 Health Partners (NASDAQ:PIII) has a market capitalization of $459.64 million and generates $1.05 billion in revenue each year. The company earns $-270,130,000.00 in net income (profit) each year or ($2,260.8101) on an earnings per share basis.

How many employees does P3 Health Partners have?

The company employs 600 workers across the globe.

How can I contact P3 Health Partners?

P3 Health Partners' mailing address is 2045 W GRAND AVE STUITE B, CHICAGO IL, 60612. The official website for the company is foresightacq.com. The company can be reached via phone at 702-910-3950 or via email at shalper@lifesciadvisors.com.

This page (NASDAQ:PIII) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -